CDC Website CDC Website

To Join the NPIN community or

Home » Advancing HIV Therapeutic Vaccine Science (U01)

Advancing HIV Therapeutic Vaccine Science (U01)

This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress viral loads in HIV-infected individuals. Applications should propose small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.
Funding Category
Locations
National
Eligible Organizations
Number of Awards Given
2-3

Minimum Amount: 

$0.00

Maximum Amount: 

$0.00

Average Amount: 

$0.00

Award Amount: 

$3,600,000.00
Award Amount Notes
NIAID intends to commit $3.6M in FY 2017 to fund 2-3 awards.
Notes
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Application Due Date
6/28/16
Application Contact
Stephen
Smiley, Ph.D.
United States
(240) 627-3071
stephen.smiley@nih.gov
(240) 627-3071
Technical Contact
GrantsInfo
GrantsInfo@nih.gov
United States
(240) 435-0714
(240) 435-0714
Fund Duration
5 years
Subjects
Audiences
Application Process
Applicants must obtain the SF424 (R&R) application package associated with this funding opportunity using the "Apply for Grant Electronically" button in the FOA or following the directions provided at Grants.gov.

Fund Number: 

RFA-AI-16-019

Fund ID: 

5131

Last Updated: 

4/13/16